TGA investigate three more blood clot cases 'likely' linked to AstraZeneca

Kathryn Lewis
Updated April 23 2021 - 10:58pm, first published 8:00pm
The Therapeutic Goods Administration said the cases were likely linked to the vaccine. Picture: Shutterstock
The Therapeutic Goods Administration said the cases were likely linked to the vaccine. Picture: Shutterstock

The Therapeutic Goods Administration is investigating three new cases of a rare blood clot syndrome "likely" linked to the AstraZeneca vaccine.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options
Kathryn Lewis

Kathryn Lewis

Canberra Times Journalist

I am a breaking and general news reporter. Contact me with tips or story ideas at kathryn.lewis@canberratimes.com.au

Get the latest Canberra news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.